Plans also unveiled for a new site in north west England during the third quarter.

NeuroClin has appointed Fiona Wood as its new chief executive.

The Glasgow-headquartered clinical research facility has also confirmed that an agreement has been reached to open a new site in north west England this autumn.Wood joins the business from Clyde Munro, where she held a number of senior leadership positions, including her most recent role as chief operating officer. She also brings experience within both the NHS and the private healthcare sector.

In addition to the new facility in England, the appointment comes following a seven figure investment made earlier this year by main backer N4 Partners, alongside previous funding from Foresight Group and Fullbrook Thorpe Investments.

Since launching in 1999, NeuroClin has carried out research into neurological conditions such as Alzheimer’s, Parkinson’s, dementia and depression.

Wood commented: “It’s great to announce our plans for a new site in England and my focus will be to work with the experienced team to further execute our growth and expansion strategy, unlocking further opportunities within the field of clinical research and continue to cement NeuroClin’s reputation as one of the world’s leading neurological research centres.”

Jeff Thomis, NeuroClin’s chair, added: “It has been very encouraging to see the progress NeuroClin has made in continuing to build on its global reputation and further diversify the research base.“A strong platform has been developed and, under Fiona’s leadership, we look ahead to further expansion.”

Insider: https://www.insider.co.uk/appointments/neuroclin-appoints-new-chief-executive-32802817